Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 17989 | 509 | 41.3 | 77% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1704 | 6129 | ALPHA1 ANTITRYPSIN DEFICIENCY//ALPHA 1 ANTITRYPSIN//EMPHYSEMA |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | COPD RELATED PHENOTYPES | Author keyword | 6 | 100% | 1% | 4 |
| 2 | IREB2 | Author keyword | 4 | 75% | 1% | 3 |
| 3 | FAM13A | Author keyword | 3 | 100% | 1% | 3 |
| 4 | LEICESTER P BIOMED UNIT | Address | 2 | 36% | 1% | 5 |
| 5 | BEHAV HLTH EPIDEMIOL PROGRAM | Address | 2 | 24% | 1% | 6 |
| 6 | MICROSOMAL EPOXIDE HYDROLASE | Author keyword | 2 | 12% | 2% | 12 |
| 7 | MOL CELLULAR PULMONOL | Address | 1 | 31% | 1% | 4 |
| 8 | PIRAT EMERGENCY | Address | 1 | 100% | 0% | 2 |
| 9 | SERPINE2 | Author keyword | 1 | 27% | 1% | 4 |
| 10 | PATHW MED WESTERN AUSTRALIA | Address | 1 | 40% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | COPD RELATED PHENOTYPES | 6 | 100% | 1% | 4 | Search COPD+RELATED+PHENOTYPES | Search COPD+RELATED+PHENOTYPES |
| 2 | IREB2 | 4 | 75% | 1% | 3 | Search IREB2 | Search IREB2 |
| 3 | FAM13A | 3 | 100% | 1% | 3 | Search FAM13A | Search FAM13A |
| 4 | MICROSOMAL EPOXIDE HYDROLASE | 2 | 12% | 2% | 12 | Search MICROSOMAL+EPOXIDE+HYDROLASE | Search MICROSOMAL+EPOXIDE+HYDROLASE |
| 5 | SERPINE2 | 1 | 27% | 1% | 4 | Search SERPINE2 | Search SERPINE2 |
| 6 | ADENOVIRUS C | 1 | 50% | 0% | 1 | Search ADENOVIRUS+C | Search ADENOVIRUS+C |
| 7 | AQUAPORIN5 | 1 | 50% | 0% | 1 | Search AQUAPORIN5 | Search AQUAPORIN5 |
| 8 | DISEASE MODULE | 1 | 50% | 0% | 1 | Search DISEASE+MODULE | Search DISEASE+MODULE |
| 9 | ENHANCER MUTATION | 1 | 50% | 0% | 1 | Search ENHANCER+MUTATION | Search ENHANCER+MUTATION |
| 10 | EPOXIDE HYDROLASE EPHX1 | 1 | 50% | 0% | 1 | Search EPOXIDE+HYDROLASE+EPHX1 | Search EPOXIDE+HYDROLASE+EPHX1 |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SERPINE2 GENE | 27 | 78% | 4% | 18 |
| 2 | SPIROMETRIC PHENOTYPES | 25 | 71% | 4% | 20 |
| 3 | HUMBOLDT FAMILY | 8 | 100% | 1% | 5 |
| 4 | MICROSOMAL EPOXIDE HYDROLASE | 6 | 10% | 11% | 54 |
| 5 | ALPHA 1 ANTITRYPSIN GENE | 5 | 27% | 3% | 15 |
| 6 | ALPHA 1 ANTICHYMOTRYPSIN GENE | 4 | 75% | 1% | 3 |
| 7 | CHRNA3 5 | 4 | 75% | 1% | 3 |
| 8 | RAPID DECLINE | 3 | 24% | 2% | 10 |
| 9 | 3 FLANKING SEQUENCE | 3 | 60% | 1% | 3 |
| 10 | TRANSFORMING GROWTH FACTOR BETA 1 GENE POLYMORPHISMS | 2 | 50% | 1% | 3 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Lessons from ECLIPSE: a review of COPD biomarkers | 2014 | 11 | 56 | 23% |
| Updates on the COPD gene list | 2012 | 14 | 357 | 47% |
| Emerging genetics of COPD | 2012 | 21 | 83 | 28% |
| Chronic obstructive pulmonary disease center dot 1: Susceptibility factors for COPD the genotype-environment interaction | 2002 | 83 | 77 | 47% |
| Interleukin-1B-31T/C promoter polymorphism and chronic obstructive pulmonary disease risk: a meta-analysis | 2014 | 0 | 9 | 67% |
| Genetic variation and gene expression in antioxidant related enzymes and risk of COPD: a systematic review | 2008 | 26 | 63 | 29% |
| Genetics of chronic obstructive pulmonary disease | 2003 | 14 | 63 | 57% |
| Gene polymorphisms and chronic obstructive pulmonary disease | 2014 | 1 | 81 | 43% |
| Update in chronic obstructive pulmonary disease: role of antioxidant and metabolizing gene polymorphisms | 2011 | 8 | 108 | 39% |
| Gene-environment interactions in the development of chronic obstructive pulmonary disease | 2006 | 8 | 25 | 64% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | LEICESTER P BIOMED UNIT | 2 | 36% | 1.0% | 5 |
| 2 | BEHAV HLTH EPIDEMIOL PROGRAM | 2 | 24% | 1.2% | 6 |
| 3 | MOL CELLULAR PULMONOL | 1 | 31% | 0.8% | 4 |
| 4 | PIRAT EMERGENCY | 1 | 100% | 0.4% | 2 |
| 5 | PATHW MED WESTERN AUSTRALIA | 1 | 40% | 0.4% | 2 |
| 6 | STUDY HLTH POMERANIA SHIP CLIN EPIDEMIOL | 1 | 40% | 0.4% | 2 |
| 7 | BUSSELTON POPULAT MED FDN | 1 | 22% | 0.8% | 4 |
| 8 | PULM DISSTATE BIOTHER Y CHINA | 1 | 27% | 0.6% | 3 |
| 9 | PULMONOL C3 P | 1 | 33% | 0.4% | 2 |
| 10 | CENT MOL | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000210280 | CIGARETTE SMOKE//EMPHYSEMA//LUNG BIOL DIS PROGRAM |
| 2 | 0.0000137702 | ADAM33//ORMDL3//ASTHMA GENET GRP |
| 3 | 0.0000115338 | CLPTM1L//CHRNA3//TERT CLPTM1L |
| 4 | 0.0000105759 | ALPHA1 ANTITRYPSIN DEFICIENCY//ALPHA 1 ANTITRYPSIN//ANTITRYPSIN |
| 5 | 0.0000097720 | COPD//CHRONIC OBSTRUCTIVE PULMONARY DISEASE//INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 6 | 0.0000090923 | SPIROMETRY//PEAK FLOW METERS//REFERENCE EQUATIONS |
| 7 | 0.0000082193 | GC GLOBULIN//VITAMIN D BINDING PROTEIN//GCMAF |
| 8 | 0.0000072416 | GSTM1//GSTT1//GSTP1 |
| 9 | 0.0000071737 | EMPHYSEMA//EMPHYSEMA PULMONARY//AIR TRAPPING |
| 10 | 0.0000070609 | EPOXIDE HYDROLASE//CIS EPOXYSUCCINATE HYDROLASE//MICROSOMAL EPOXIDE HYDROLASE |